3de Jong MD,Tran TT,Truong HK,et al. Oseltamivir resistance during treatment of influenza A ( H5N1 ) infection[ J]. N Engl J Med,2005 , 353 (25) :2667 - 2672.
4Tree JA, Richardson C, Fook AR ,et al. Comparison of large - scale mammalian cell culture systems with egg culture for the production of influenza virus A vaccine strains[J]. J Med Virol, 2001,65:163 -170.
5Noyola DE, Paredes AG, Clark B, et al. Evaluation of a neuraminidase detection assay for the rapid detection of influenza A and B virus in children [ J ]. Pediatr Dev Pathol,2000,3 ( 2 ) : 162 - 167.
6Noyola DE,Clark B,O'Donnell FT,et al. Comparison of a new neuraminidase detection assay with an enzyme i mmunoassay, immunofluorescence, and culture for rapid detection of influenza A and B viruses in nasal wash specimens[ J]. J Clin Microbiol,2000,38 (3) : 1161 - 1165.
7Tsang KW, Ho PL, Ooi GC, et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong [ J ]. N Engl J Med,2003 ,348 (20) : 1977 - 1985.
8Cumulative number of reported probable cases of severe acute respiratory syndrome( SARS ) [ EB/OL ]. http ://www. who. int/csr/sars/country, 2003 - 05 - 13.
9Treanor J J, Hayden FG, Vrooman PS,et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: A randomized controlled trial. US Oral Neuraminidase Study Group [ J ]. JAMA, 2000,283 (8) : 1016 - 1024.
10Kaiser L, Wat C, Mills T, et al. Impact of oseltamivir treatment on influenza - related lower respiratory tract complications and hospita/izations [ J ]. Arch Intern Med,2003,163 (14) : 1667 - 1672.
